Clinical Trial Update: Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG) in healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Zika Virus Disease
• Zika Virus Infection

Drugs mentioned

• Zika Virus Immune Globulin (ZIKV-IG)

Snippet

Sponsor: Emergent BioSolutions | Conditions: Zika Virus Infection, Zika Virus Disease | Phase 1 | Status: COMPLETED | Results posted: 2020-07-13